Adaptive Biotechnologies Corp financial data

Symbol
ADPT on Nasdaq
Location
1165 Eastlake Ave E, Seattle, WA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 300 % -28%
Quick Ratio 9.81 % -35.7%
Debt-to-equity 162 % +23.6%
Return On Equity -41 % +45%
Return On Assets -15.6 % +51.5%
Operating Margin -30.9 % +72.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 153M shares +3.45%
Common Stock, Shares, Outstanding 153M shares +3.4%
Entity Public Float 416M USD -45%
Common Stock, Value, Issued 15K USD +7.14%
Weighted Average Number of Shares Outstanding, Basic 152M shares +3.33%
Weighted Average Number of Shares Outstanding, Diluted 163M shares +10.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 253M USD +42.6%
Research and Development Expense 95.2M USD -12.3%
Selling and Marketing Expense 91.7M USD +7.73%
General and Administrative Expense 71.2M USD -5.67%
Costs and Expenses 331M USD -12.2%
Operating Income (Loss) -78.2M USD +60.9%
Net Income (Loss) Attributable to Parent -79.6M USD +59.2%
Earnings Per Share, Basic 0 USD/shares +60.4%
Earnings Per Share, Diluted 0 USD/shares +60.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 55M USD +44.5%
Accounts Receivable, after Allowance for Credit Loss, Current 44.8M USD +9.82%
Inventory, Net 9.93M USD -16.9%
Assets, Current 281M USD -8.73%
Property, Plant and Equipment, Net 37.5M USD -26.9%
Operating Lease, Right-of-Use Asset 42M USD -9.76%
Goodwill 119M USD 0%
Other Assets, Noncurrent 1.84M USD -30.7%
Assets 491M USD -12.2%
Accounts Payable, Current 10.3M USD +39.7%
Employee-related Liabilities, Current 12.7M USD +2.79%
Accrued Liabilities, Current 7.21M USD +18.9%
Contract with Customer, Liability, Current 41.3M USD -20.3%
Liabilities, Current 83.4M USD -4.87%
Contract with Customer, Liability, Noncurrent 1.21M USD -96.3%
Operating Lease, Liability, Noncurrent 72.4M USD -11.5%
Other Liabilities, Noncurrent 20K USD 0%
Liabilities 286M USD -14.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 211K USD -57.5%
Retained Earnings (Accumulated Deficit) -1.35B USD -6.27%
Stockholders' Equity Attributable to Parent 204M USD -8.64%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 204M USD -8.64%
Liabilities and Equity 491M USD -12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.5M USD +25.7%
Net Cash Provided by (Used in) Financing Activities 5.45M USD +12289%
Net Cash Provided by (Used in) Investing Activities 25.6M USD -42.5%
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 153M shares +3.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.54M USD -59%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.37M USD +3.67%
Deferred Tax Assets, Valuation Allowance 436M USD +8.22%
Deferred Tax Assets, Gross 447M USD +7.23%
Operating Lease, Liability 81.8M USD -10.9%
Depreciation 4.31M USD -10%
Payments to Acquire Property, Plant, and Equipment 1.26M USD -16.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -79.9M USD +58.9%
Lessee, Operating Lease, Liability, to be Paid 97.1M USD -12.6%
Property, Plant and Equipment, Gross 136M USD -3.55%
Operating Lease, Liability, Current 9.44M USD -5.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.9M USD -3.13%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.3M USD -12.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15.3M USD -20.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.3M USD +2.83%
Deferred Tax Assets, Operating Loss Carryforwards 275M USD +9.06%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 10.7M USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.6M USD +2.83%
Operating Lease, Payments 3M USD -18.9%
Additional Paid in Capital 1.55B USD +4.06%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD -0.35%
Deferred Tax Assets, Net of Valuation Allowance 11.6M USD -20.2%
Share-based Payment Arrangement, Expense 51.6M USD -8.41%
Interest Expense 11.8M USD +1.17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%